Solutions by Modality
Cell-based Therapeutic Modalities
We specialize in preclinical studies of cell-based therapeutics, including CAR-T, CAR-NK, and MSC (mesenchymal stem cell) therapies. These innovative treatments target cancers and refractory diseases (CAR-T/NK) or support tissue regeneration and inflammation control (MSC).
Key Services
- Efficacy evaluation: Tumor cell-killing ability and tissue regeneration effects
- Safety studies: Evaluation of tumorigenesis and immune rejection
- Distribution studies: qPCR-based evaluation of in vivo distribution
Highlights
- IND packaging expertise for CAR-T therapies (first in Korea)
- Extensive experience in CAR-NK and enhanced MSC-based therapeutic research
- Tailored experimental designs and compliance with global regulatory standards